Management Options in Breast Cancer Case Histories, Best Practice, and Clinical Decision-Making

Management Options in Breast Cancer is the only comprehensive resource devoted to exploring the systematic approach to breast cancer diagnosis, surgery, and postoperative care. This guide is an ideal tool for oncologists, pathologists, radiologists, and gynecologists seeking alternative management options for breast cancer. In addition, trainees will find this text a valuable reference for learning the basic principles and clinical guidelines of the field.

Key features in this stand-alone text:

• an international review of the management options in the field of breast cancer clinical practice
• case-based examples designed to aid in optimal clinician decision-making
• two chapters devoted to rarely-explored topics: male breast cancer and geriatric breast cancer

Preface. Acknowledgments. 1. Early Symptomatic Breast Cancer. Part I: Mastectomy. Case Study 1. Case Study 2. Case Study 3. Case Study 4. Case Study 5. Part II: Breast Conservation Therapy. Case Study 6. Case Study 7. Case Study 8. Case Study 9. Case Study 10. Case Study 11. 2. Screen-Detected Breast Cancer. Part I: Mastectomy. Case Study 12. Part II: Breast Conservation Therapy. Case Study 13. Case Study 14. Case Study 15. 3. Incidental Breast Cancer. Part I: Mastectomy. Case Study 16. Case Study 17. Case Study 18. Part II: Breast-Conservation Surgery. Case Study 19. 4. Ipsilateral Breast Tumor Recurrence. Case Study 20. 5. Diagnostic Excision Biopsy. Case Study 21. 6. Bilateral Breast Cancer. Case Study 22. Case Study 23. Case Study 24. 7. Inflammatory Breast Cancer. Case Study 25. Case Study 26. 8. Neoadjuvant Chemotherapy. Part I: Mastectomy Postchemotherapy Case Study 27. Case Studies. Part II: Breast Conservation Surgery Postchemotherapy. Case Study 28. 9. Primary Endocrine Therapy. Part I: Mastectomy after Primary Endocrine Therapy. Case Study 29. Case Study 30. Part II: Breast-Conservation Surgery after Primary Endocrine Therapy. Case Study 31. 10. Breast Cancer in the Elderly. Part I: Primary Endocrine Therapy. Case Study 32. Part II: Primary Radiotherapy. Case Study 33. 11: Pregnancy-Related Breast Cancer. Part I: First Trimester Pregnancy. Case Study 34. Part II: Third Trimester Pregnancy. Case Study 35. Case Study 36. 12. Prophylactic Mastectomy. Part I: Bilateral Prophylactic Mastectomy. Case Study 37. Part II: Contralateral Prophylactic Mastectomy. Case Study 38. 13. Lymphedema. Case Study 39. 14. Miscellaneous Conditions. Part I: Male Breast Cancer. Case Study 40. Case Study. 41. Part II: Paget’s Disease. Case Study 42. Part III: Phylloides Tumour. Case Study 43. Appendices. Index.

JOHN BENSON is a Consultant Breast Surgeon in the Cambridge Breast Unit, Addenbrooke’s Hospital and a Fellow of Selwyn College, Cambridge. Dr. Benson received his Doctorate (DM) from the University of Oxford and underwent specialist training at The Royal Marsden Hospital and Institute of Cancer Research, London. He is Director of Clinical Studies at Selwyn College and was appointed a Regional Breast Tutor by the Royal College of Surgeons of England in 2007. Dr. Benson has published widely in the field of breast diseases and has coordinated a major article on breast cancer for The Lancet. He is a Fellow of the Royal College of Surgeons of England and Edinburgh and an Examiner for the Intercollegiate Membership Examination (MRCS). His is member of the British Breast Group and the American Association for Cancer Research.

ISMAIL JATOI is Professor of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. He is also Director of the Breast Care Center, National Naval Medical Center, Bethesda, Maryland, USA. Dr. Jatoi received his Ph.D. and M.D. degrees from Saint Louis University, Saint Louis, Missouri, USA. He is Diplomate of the American Board of Surgery and Fellow of the American College of Surgeons. Dr. Jatoi has had a long-standing interest in the management of breast cancer and has published numerous articles, book chapters, and books related to breast cancer local therapy and epidemiology. He has served on the Breast Cancer Executive Committee of the Southwest Oncology Group and the Cancer Prevention Committee of the American Society of Clinical Oncology.